PKP2基因家系突变与致心律失常性右室心肌病表型分析1例

方旭, 程维礼, 任重远, 等. PKP2基因家系突变与致心律失常性右室心肌病表型分析1例[J]. 临床心血管病杂志, 2024, 40(6): 508-512. doi: 10.13201/j.issn.1001-1439.2024.06.016
引用本文: 方旭, 程维礼, 任重远, 等. PKP2基因家系突变与致心律失常性右室心肌病表型分析1例[J]. 临床心血管病杂志, 2024, 40(6): 508-512. doi: 10.13201/j.issn.1001-1439.2024.06.016
FANG Xu, CHENG Weili, REN Zhongyuan, et al. Family mutation of PKP2 gene and arrhythmogenic right ventricular cardiomyopathy phenotypic analysis: one case report[J]. J Clin Cardiol, 2024, 40(6): 508-512. doi: 10.13201/j.issn.1001-1439.2024.06.016
Citation: FANG Xu, CHENG Weili, REN Zhongyuan, et al. Family mutation of PKP2 gene and arrhythmogenic right ventricular cardiomyopathy phenotypic analysis: one case report[J]. J Clin Cardiol, 2024, 40(6): 508-512. doi: 10.13201/j.issn.1001-1439.2024.06.016

PKP2基因家系突变与致心律失常性右室心肌病表型分析1例

  • 基金项目:
    南京医科大学科技发展基金项目(No:NMUB20210156)
详细信息

Family mutation of PKP2 gene and arrhythmogenic right ventricular cardiomyopathy phenotypic analysis: one case report

More Information
  • 1例青年男性患者经相关检查确诊为致心律失常性右室心肌病(ARVC)先证者后,收集先证者家系的临床资料,对先证者及发病家系成员进行全基因组测序,筛选可疑致病基因,并通过Sanger测序法进行验证。对该家系筛查发现先证者及其母亲均为PKP2基因c.517C>T杂合无义突变携带者,余家系成员及对照组均未携带该致病突变。本研究发现PKP2基因家系突变可能导致家族性遗传,其表型分析符合典型ARVC临床特点并且无左室功能受累。
  • 加载中
  • 图 1  先证者室性心动过速发作心电图

    Figure 1.  Ventricular tachycardia of progenitor in ECG

    图 2  先证者心电图V1~V4T波倒置

    Figure 2.  V1-V4T waves Inversion in progenitor

    图 3  先证者超声心动图

    Figure 3.  Progenitor echocardiography

    图 4  先证者心脏磁共振

    Figure 4.  Cardiac magnetic resonance of progenitor

    图 5  先证者行导管射频消融术

    Figure 5.  The progenitor underwent radiofrequency catheter ablation

    图 6  先证者母亲

    Figure 6.  The mother of progenitor

    图 7  先证者母亲超声心动图

    Figure 7.  Ultrasound cardiogram of progenitor's mother

    图 8  先证者母亲磁共振

    Figure 8.  Magnetic resonance of progenitor's mother

    图 9  基因突变

    Figure 9.  Genetic mutations

    图 10  蛋白三维结构图

    Figure 10.  Three-dimensional structure of protein

  • [1]

    Goff ZD, Calkins H. Sudden death related cardiomyopathies-Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy[J]. Prog Cardiovasc Dis, 2019, 62(3): 217-226. doi: 10.1016/j.pcad.2019.04.002

    [2]

    Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria[J]. Eur Heart J, 2010, 31(7): 806-814. doi: 10.1093/eurheartj/ehq025

    [3]

    Wang W, Tichnell C, Murray BA, et al. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients[J]. Europace, 2020, 22(8): 1270-1278. doi: 10.1093/europace/euaa105

    [4]

    Bosman LP, Te Riele A. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification[J]. Heart, 2022, 108(2): 90-97. doi: 10.1136/heartjnl-2021-319113

    [5]

    Protonotarios A, Bariani R, Cappelletto C, et al. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator[J]. Eur Heart J, 2022, 43(32): 3053-3067. doi: 10.1093/eurheartj/ehac235

    [6]

    Gandjbakhch E, Redheuil A, Pousset F, et al. Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review[J]. J Am Coll Cardiol, 2018, 72(7): 784-804. doi: 10.1016/j.jacc.2018.05.065

    [7]

    中华医学会心血管病学分会精准心血管病学学组, 中国医疗保健国际交流促进会, 精准心血管病分会, 等. 单基因遗传性心血管疾病基因诊断指南[J]. 中华心血管病杂志, 2019, 47(3): 175-195. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202004008.htm

    [8]

    Bhonsale A, Groeneweg JA, James CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers[J]. Eur Heart J, 2015, 36(14): 847-855. doi: 10.1093/eurheartj/ehu509

    [9]

    Hermida A, Fressart V, Hidden-Lucet F, et al. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia[J]. Eur J Heart Fail, 2019, 21(6): 792-800. doi: 10.1002/ejhf.1423

    [10]

    Biernacka EK, Borowiec K, Franaszczyk M, et al. Pathogenic variants in plakophilin-2 gene(PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy[J]. J Appl Genet, 2021, 62(4): 613-620. doi: 10.1007/s13353-021-00647-y

    [11]

    Bhonsale A, Groeneweg JA, James CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers[J]. Eur Heart J, 2015, 36(14): 847-855. doi: 10.1093/eurheartj/ehu509

    [12]

    Belhassen B, Laredo M, Roudijk RW, et al. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy[J]. Europace, 2022, 24(2): 285-295. doi: 10.1093/europace/euab190

    [13]

    Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy[J]. Nat Rev Cardiol, 2019, 16(9): 519-537. doi: 10.1038/s41569-019-0200-7

    [14]

    van Opbergen CJ, Delmar M, van Veen TA. Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways[J]. Neth Heart J, 2017, 25(3): 157-169. doi: 10.1007/s12471-017-0946-7

    [15]

    Cerrone M, Montnach J, Lin X, et al. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm[J]. Nat Commun, 2017, 8(1): 106. doi: 10.1038/s41467-017-00127-0

    [16]

    Franklin BA, Thompson PD, Al-Zaiti SS, et al. Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American Heart Association[J]. Circulation, 2020, 141(13): e705-e736.

    [17]

    中国医药卫生文化协会心血管健康与科学运动分会. 运动相关心血管事件风险的评估与监测中国专家共识[J]. 中国循环杂志, 2022, 37(7): 659-668. doi: 10.3969/j.issn.1000-3614.2022.07.002

    [18]

    Bosman LP, Cadrin-Tourigny J, Bourfiss M, et al. Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation[J]. Europace, 2020, 22(5): 787-796. doi: 10.1093/europace/euaa039

    [19]

    Andrews CM, Srinivasan NT, Rosmini S, et al. Electrical and Structural Substrate of Arrhythmogenic Right Ventricular Cardiomyopathy Determined Using Noninvasive Electrocardiographic Imaging and Late Gadolinium Magnetic Resonance Imaging[J]. Circ Arrhythm Electrophysiol, 2017, 10(10): 110.

    [20]

    梁晴, 陶琴. JPH2基因p. R616C突变与家族性扩张型心肌病的相关性分析[J]. 临床心血管病杂志, 2023, 39(4): 303-307. https://lcxxg.whuhzzs.com/article/doi/10.13201/j.issn.1001-1439.2023.04.013

    [21]

    van Opbergen C, Bagwan N, Maurya SR, et al. Exercise causes arrhythmogenic remodeling of intracellular calcium dynamics in plakophilin-2-deficient hearts[J]. Circulation, 2022, 145(19): 1480-1496. doi: 10.1161/CIRCULATIONAHA.121.057757

    [22]

    Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy[J]. Eur Heart J, 2022, 43(32): e1-e9. doi: 10.1093/eurheartj/ehac180

  • 加载中
计量
  • 文章访问数:  173
  • 施引文献:  0
出版历程
收稿日期:  2023-08-02
刊出日期:  2024-06-13

返回顶部

目录